Summit Therapeutics Inc.

SMMT

$ -

Review earnings summary, surprise history, and upcoming forecasts.

account_balance_walletEarnings Summary

Updated: 07/23/2026FY2026 Q2

Revenue (TTM)

0M USD

YoY -

Net Income (TTM)

-2.2B USD

YoY Reduced Deficit

Equity Ratio

83.8%

YoY +3.7pt

BPS

0.81$

YoY +215.8%

Revenue

FY2024 Q3$0

FY2024 Q4$0

FY2025 Q1$0

FY2025 Q2$0

FY2025 Q3$0

FY2025 Q4$0

FY2026 Q1$0

FY2026 Q2$0

Actual

YoY$0 (-)

Net Income

$-405.1M

FY2024 Q3$-124.3M

$-124.3M

FY2024 Q4$-173.2M

$-173.2M

Surprise History

Actual RevenueAnalyst Estimate

FY2021MISS

Actual:$1.3M

Est:$1.6M

FY2021MISS

$1.3M

Earnings Release History